MEPE's diverse effects on mineralization

Calcified Tissue International

Volumn 86, Issue 1, 2010, Pages 42-46

  Boskey, Adele L ^a   Chiang, Phyllis ^a   Fermanis, Alexis ^a   Brown, Jared ^a   Taleb, Hayat ^a   David, Valentin ^b   Rowe, Peter S N ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

ASARM peptide; Matrix extracellular phosphoglycoprotein; Mineralization; Posttranslational modification

Indexed keywords

ASPARTIC ACID; FIBRILLAR COLLAGEN; GLYCOPROTEIN; HYDROXYAPATITE; PHOSPHOGLYCOPROTEIN; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BIOMINERALIZATION; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; ROOM TEMPERATURE;

BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; COLLAGEN TYPE I; CRYSTALLIZATION; DURAPATITE; EXTRACELLULAR MATRIX PROTEINS; GELS; GLYCOPROTEINS; HUMANS; OSTEOMALACIA; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN MODIFICATION, TRANSLATIONAL;

EID: 73649134967     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-009-9313-z     Document Type: Article

References (29)

1. PS Rowe PA de Zoysa R Dong HR Wang KE White MJ Econs CL Oudet 2000 MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia Genomics 67 54 68 10.1006/geno.2000.6235 10.1006/geno.2000.6235 1:CAS:528: DC%2BD3cXlslylsLs%3D 10945470 (Pubitemid 30471121)
2. L Argiro M Desbarats FH Glorieux B Ecarot 2001 Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone Genomics 74 342 351 10.1006/geno.2001.6553 10.1006/geno.2001.6553 1:CAS:528:DC%2BD3MXksVChs7k%3D 11414762 (Pubitemid 32675358)
3. NL Huq KJ Cross M Ung EC Reynolds 2005 A review of protein structure and gene organisation for proteins associated with mineralised tissue and calcium phosphate stabilisation encoded on human chromosome 4 Arch Oral Biol 50 599 609 10.1016/j.archoralbio.2004.12.009 10.1016/j.archoralbio.2004.12.009 1:CAS:528:DC%2BD2MXktVOgsL8%3D 15892946 (Pubitemid 40689531)
4. A Nampei J Hashimoto K Hayashida H Tsuboi K Shi I Tsuji H Miyashita T Yamada N Matsukawa M Matsumoto S Morimoto T Ogihara T Ochi H Yoshikawa 2004 Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone J Bone Miner Metab 22 176 184 10.1007/s00774-003-0468-9 10.1007/s00774-003-0468-9 1:CAS:528:DC%2BD2cXjtlyjsbs%3D 15108058 (Pubitemid 38660947)
5. LC Gowen DN Petersen AL Mansolf H Qi JL Stock GT Tkalcevic HA Simmons DT Crawford KL Chidsey-Frink HZ Ke JD McNeish TA Brown 2003 Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass J Biol Chem 278 1998 2007 10.1074/jbc.M203250200 10.1074/jbc.M203250200 1:CAS:528:DC%2BD3sXisFyrsQ%3D%3D 12421822 (Pubitemid 36801442)
6. A Martin V David JS Laurence PM Schwarz EM Lafer AM Hedge PS Rowe 2008 Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP Endocrinology 149 1757 1772 10.1210/en.2007-1205 10.1210/en.2007-1205 1:CAS:528:DC%2BD1cXktVeqs7o%3D 18162525
7. PS Rowe Y Kumagai G Gutierrez IR Garrett R Blacher D Rosen J Cundy S Navvab D Chen MK Drezner LD Quarles GR Mundy 2004 MEPE has the properties of an osteoblastic phosphatonin and minhibin Bone 34 303 319 10.1016/j.bone.2003.10. 005 10.1016/j.bone.2003.10.005 1:CAS:528:DC%2BD2cXhtFWmsrY%3D 14962809 (Pubitemid 38177612)
8. WN Addison Y Nakano T Loisel P Crine MD McKee 2008 MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM J Bone Miner Res 23 1638 1649 10.1359/jbmr.080601 10.1359/jbmr.080601 1:CAS:528:DC%2BD1cXht1OntLfP 18597632
9. PS Rowe IR Garrett PM Schwarz DL Carnes EM Lafer GR Mundy GE Gutierrez 2005 Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP) Bone 36 33 46 10.1016/j.bone.2004.09.015 10.1016/j.bone.2004.09.015 1:CAS:528:DC%2BD2MXkvVeqsg%3D%3D 15664000 (Pubitemid 40128272)
10. R Guo PS Rowe S Liu LG Simpson ZS Xiao LD Quarles 2002 Inhibition of MEPE cleavage by Phex Biochem Biophys Res Commun 297 38 45 10.1016/S0006-291X(02) 02125-3 1:CAS:528:DC%2BD38Xms1GntrY%3D 12220505
11. L Silverman AL Boskey 2004 Diffusion systems for evaluation of biomineralization Calcif Tissue Int 75 494 501 10.1007/s00223-004-0019-y 10.1007/s00223-004-0019-y 1:CAS:528:DC%2BD2MXksVGqtQ%3D%3D 15455184 (Pubitemid 40174508)
12. JB Willis 1980 Determination of metals in blood serum by atomic absorption spectroscopy. I. Calcium Spectrochim Acta 16 259 272 10.1016/0371-1951(60)80089-6
13. JK Heinonen RJ Lahti 1981 A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphates Anal Biochem 113 313 317 10.1016/0003-2697(81)90082-8 1:CAS:528:DyaL3MXksFKqsr0%3D 6116463 (Pubitemid 11012541)
14. AP Sprowson AW McCaskie MA Birch 2008 ASARM-truncated MEPE and AC-100 enhance osteogenesis by promoting osteoprogenitor adhesion J Orthop Res 26 1256 1262 10.1002/jor.20606 10.1002/jor.20606 1:CAS:528:DC%2BD1cXhtVGhu7vF 18383145
15. T Hayashibara T Hiraga B Yi M Nomizu Y Kumagai R Nishimura T Yoneda 2004 A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo J Bone Miner Res 19 455 462 10.1359/JBMR.0301263 10.1359/JBMR.0301263 1:CAS:528:DC%2BD2cXisFCrtrg%3D 15040834 (Pubitemid 38787401)
16. N Six D Septier C Chaussain-Miller R Blacher P DenBesten M Goldberg 2007 Dentonin, a MEPE fragment, initiates pulp-healing response to injury J Dent Res 86 780 785 10.1177/154405910708600818 1:CAS:528:DC%2BD2sXpsF2qu74%3D 17652210
17. H Liu W Li S Shi S Habelitz C Gao P Denbesten 2005 MEPE is downregulated as dental pulp stem cells differentiate Arch Oral Biol 50 923 928 10.1016/j.archoralbio.2005.03.003 10.1016/j.archoralbio.2005.03.003 1:CAS:528:DC%2BD2MXhtVeiu7vN 16183369 (Pubitemid 41393049)
18. H Siggelkow E Schmidt B Hennies M Hüfner 2004 Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts Bone 35 570 576 10.1016/j.bone.2004.03.033 10.1016/j.bone.2004.03.033 1:CAS:528:DC%2BD2cXmtVWitLs%3D 15268910 (Pubitemid 38953206)
19. GS Baht GK Hunter HA Goldberg 2008 Bone sialoprotein-collagen interaction promotes hydroxyapatite nucleation Matrix Biol 27 600 608 10.1016/j.matbio. 2008.06.004 10.1016/j.matbio.2008.06.004 1:CAS:528:DC%2BD1cXhtlSgsbjN 18620053
20. V David A Martin A-M Hedge PSN Rowe 2009 MEPE is a new bone renal hormone and vascularization modulator Endocrinology 150 4012 4023 10.1210/en.2009-0216 10.1210/en.2009-0216 1:CAS:528:DC%2BD1MXhtFyrtLjI 19520780
21. C Qin O Baba WT Butler 2004 Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis Crit Rev Oral Biol Med 15 126 136 10.1177/154411130401500302 1:STN:280:DC%2BD2c3os1Khsw%3D%3D 15187031
22. AL Boskey M Maresca W Ullrich SB Doty WT Butler CW Prince 1993 Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel Bone Miner 22 147 159 10.1016/S0169- 6009(08)80225-5 1:CAS:528:DyaK2cXnsVagtQ%3D%3D 8251766
23. A Gericke C Qin L Spevak Y Fujimoto WT Butler ES Sørensen A Boskey 2005 Importance of phosphorylation for osteopontin regulation of biomineralization Calcif Tissue Int 77 45 54 10.1007/s00223-004-1288-1 10.1007/s00223-004-1288-1 1:CAS:528:DC%2BD2MXpvVCmtrs%3D 16007483 (Pubitemid 41504172)
24. PH Tartaix M Doulaverakis A George LW Fisher WT Butler C Qin E Salih M Tan Y Fujimoto L Spevak AL Boskey 2004 In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions J Biol Chem 279 18115 18120 10.1074/jbc.M314114200 10.1074/jbc.M314114200 1:CAS:528:DC%2BD2cXjsVKntrc%3D 14769788 (Pubitemid 38623223)
25. S Gajjeraman K Narayanan J Hao C Qin A George 2007 Matrix macromolecules in hard tissues control the nucleation and hierarchical assembly of hydroxyapatite J Biol Chem 282 1193 1204 10.1074/jbc.M604732200 10.1074/jbc.M604732200 1:CAS:528:DC%2BD2sXit1Kksg%3D%3D 17052984 (Pubitemid 47076548)
26. AL Boskey M Maresca S Doty B Sabsay A Veis 1990 Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth Bone Miner 11 55 65 10.1016/0169-6009(90)90015-8 1:CAS:528:DyaK3MXpvVygtA%3D%3D 2176557 (Pubitemid 20340688)
27. G He A Ramachandran T Dahl S George D Schultz D Cookson A Veis A George 2005 Phosphorylation of phosphophoryn is crucial for its function as a mediator of biomineralization J Biol Chem 280 33109 33114 10.1074/jbc.M500159200 10.1074/jbc.M500159200 1:CAS:528:DC%2BD2MXhtVens7nF 16046405 (Pubitemid 41397106)
28. A Boskey L Spevak M Tan SB Doty WT Butler 2000 Dentin sialoprotein (DSP) has limited effects on in vitro apatite formation and growth Calcif Tissue Int 67 472 478 10.1007/s002230001169 1:CAS:528:DC%2BD3MXhvVOruro%3D 11289697 (Pubitemid 32221596)
29. GK Hunter HA Goldberg 1993 Nucleation of hydroxyapatite by bone sialoprotein Proc Natl Acad Sci USA 90 8562 8565 10.1073/pnas.90.18.8562 1:CAS:528:DyaK2cXlsVCm 8397409